Τα νέα φάρμακα που θα κυκλοφορήσουν στην Ευρωπαϊκή Ένωση

Τα νέα φάρμακα που θα κυκλοφορήσουν στην Ευρωπαϊκή Ένωση

7 drugs that raised eyebrows in Q3

7 drugs that raised eyebrows in Q3

New AHA/ACC Cholesterol Treatment Guideline Expands Role of LDL Targets

New AHA/ACC Cholesterol Treatment Guideline Expands Role of LDL Targets

The top 10 drugmakers of 2024

The top 10 drugmakers of 2024

FDA Action Alert: Mallinckrodt, Kala Pharma, Merck, Eisai and More

It’s a busy week on the U.S. Food and Drug Administration (FDA)’s calendar, although the agency got ahead of itself and approved three of the applications early. Here’s a look. Agios Pharmaceuticals had a Prescription Drug User Fee Act (PDUFA) action date of Tuesday, August 21, for its ivosidenib (AG-120) for patients with relapsed or refractory (R/R) acute myeloid leukemia … Συνεχίστε να διαβάζετε FDA Action Alert: Mallinckrodt, Kala Pharma, Merck, Eisai and More.

Pharma Q2 Results Preview: Pfizer, Teva, Shire, Sanofi And Novo Nordisk

What Did Ian Read Learn From Trump? Pfizer Inc. CEO Ian Read may have as much insight as anyone in the pharma world into US President Donald Trump's thinking on drug pricing and potential policy steps, after talking to the president on the phone and visiting him at the White House in July. You can bet … Συνεχίστε να διαβάζετε Pharma Q2 Results Preview: Pfizer, Teva, Shire, Sanofi And Novo Nordisk.